Cargando…
Synthesis and release behavior of layered double hydroxides–carbamazepine composites
Carbamazepine (CBZ) was incorporated into layered double hydroxides (LDH) to be used as a controlled drug system in solid tumors. CBZ has a formal charge of zero, so its incorporation in the anionic clay implies a challenge. Aiming to overcome this problem, CBZ was loaded into LDH with sodium cholat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523521/ https://www.ncbi.nlm.nih.gov/pubmed/34663824 http://dx.doi.org/10.1038/s41598-021-00117-9 |
_version_ | 1784585319182499840 |
---|---|
author | Peralta, Ma. F. Mendieta, S. N. Scolari, I. R. Granero, G. E. Crivello, M. E. |
author_facet | Peralta, Ma. F. Mendieta, S. N. Scolari, I. R. Granero, G. E. Crivello, M. E. |
author_sort | Peralta, Ma. F. |
collection | PubMed |
description | Carbamazepine (CBZ) was incorporated into layered double hydroxides (LDH) to be used as a controlled drug system in solid tumors. CBZ has a formal charge of zero, so its incorporation in the anionic clay implies a challenge. Aiming to overcome this problem, CBZ was loaded into LDH with sodium cholate (SC), a surfactant with negative charge and, for comparison, without SC by the reconstruction method. Surprisingly, it was found that both resultant nanocomposites had similar CBZ encapsulation efficiency, around 75%, and the LDH-CBZ system without SC showed a better performance in relation to the release kinetics of CBZ in simulated body fluid (pH 7.4) and acetate buffer simulating the cellular cytoplasm (pH 4.8) than the system with SC. The CBZ dimensions were measured with Chem3D and, according to the basal spacing obtained from X-ray patterns, it can be arranged in the LDH-CBZ system as a monolayer with the long axis parallel to the LDH layers. Fourier transform infrared spectroscopy and solid state NMR measurements confirmed the presence of the drug, and thermogravimetric analyses showed an enhanced thermal stability for CBZ. These results have interesting implications since they increase the spectrum of LDH application as a controlled drug system to a large number of nonionic drugs, without the addition of other components. |
format | Online Article Text |
id | pubmed-8523521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85235212021-10-20 Synthesis and release behavior of layered double hydroxides–carbamazepine composites Peralta, Ma. F. Mendieta, S. N. Scolari, I. R. Granero, G. E. Crivello, M. E. Sci Rep Article Carbamazepine (CBZ) was incorporated into layered double hydroxides (LDH) to be used as a controlled drug system in solid tumors. CBZ has a formal charge of zero, so its incorporation in the anionic clay implies a challenge. Aiming to overcome this problem, CBZ was loaded into LDH with sodium cholate (SC), a surfactant with negative charge and, for comparison, without SC by the reconstruction method. Surprisingly, it was found that both resultant nanocomposites had similar CBZ encapsulation efficiency, around 75%, and the LDH-CBZ system without SC showed a better performance in relation to the release kinetics of CBZ in simulated body fluid (pH 7.4) and acetate buffer simulating the cellular cytoplasm (pH 4.8) than the system with SC. The CBZ dimensions were measured with Chem3D and, according to the basal spacing obtained from X-ray patterns, it can be arranged in the LDH-CBZ system as a monolayer with the long axis parallel to the LDH layers. Fourier transform infrared spectroscopy and solid state NMR measurements confirmed the presence of the drug, and thermogravimetric analyses showed an enhanced thermal stability for CBZ. These results have interesting implications since they increase the spectrum of LDH application as a controlled drug system to a large number of nonionic drugs, without the addition of other components. Nature Publishing Group UK 2021-10-18 /pmc/articles/PMC8523521/ /pubmed/34663824 http://dx.doi.org/10.1038/s41598-021-00117-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Peralta, Ma. F. Mendieta, S. N. Scolari, I. R. Granero, G. E. Crivello, M. E. Synthesis and release behavior of layered double hydroxides–carbamazepine composites |
title | Synthesis and release behavior of layered double hydroxides–carbamazepine composites |
title_full | Synthesis and release behavior of layered double hydroxides–carbamazepine composites |
title_fullStr | Synthesis and release behavior of layered double hydroxides–carbamazepine composites |
title_full_unstemmed | Synthesis and release behavior of layered double hydroxides–carbamazepine composites |
title_short | Synthesis and release behavior of layered double hydroxides–carbamazepine composites |
title_sort | synthesis and release behavior of layered double hydroxides–carbamazepine composites |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523521/ https://www.ncbi.nlm.nih.gov/pubmed/34663824 http://dx.doi.org/10.1038/s41598-021-00117-9 |
work_keys_str_mv | AT peraltamaf synthesisandreleasebehavioroflayereddoublehydroxidescarbamazepinecomposites AT mendietasn synthesisandreleasebehavioroflayereddoublehydroxidescarbamazepinecomposites AT scolariir synthesisandreleasebehavioroflayereddoublehydroxidescarbamazepinecomposites AT graneroge synthesisandreleasebehavioroflayereddoublehydroxidescarbamazepinecomposites AT crivellome synthesisandreleasebehavioroflayereddoublehydroxidescarbamazepinecomposites |